The use of pharmacotherapy to treat psychiatric and neurological disorders has become an increasingly broad and complex part of health care. The complexity of the brain and behavior yield highly specialized areas of study that are then utilized to develop effective pharmacotherapeutic interventions. Knowledge of the treatment of diseases of the brain and behavior is critical to those treating other disease states due to the impact these disorders and medications can have on overall health. Neuropsychiatric pharmacotherapy covers important topics in the treatment of psychiatric and neurologic disorders such as schizophrenia, bipolar disorder, major depressive disorder, anxiety disorders, childhood psychiatric disorders, sleep disorders, substance use disorders, dementia and other special topics in the specialty of neuropsychopharmacology. This course is an elective designed to cover core clinical sciences beyond the general therapeutics modules on neuropsychiatric topics and will expand on the teaching covered in the core clinical science course. (PHAR 595)
You're Invited to Join KGI for our In-Person Visit Day! October 19 | 9 a.m. - 2:30 p.m. PST. REGISTER TODAY.